ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
Rhea-AI Summary
ICU Medical (Nasdaq: ICUI) will release first quarter 2026 results on May 7, 2026 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will host a conference call at 4:30 p.m. ET (1:30 p.m. PT) the same day.
Investors can join by phone at 1-800-343-4136 with conference ID ICUMED or listen via webcast on the company's investor website; a replay will be available.
Positive
- None.
Negative
- None.
News Market Reaction – ICUI
In the Apr 23 session, ICUI declined 2.21%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 05 | Earnings call timing | Neutral | -0.2% | Announced release and conference call time for Q4 2025 earnings. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings date/conference-call timing news led to a modest -0.23% move, suggesting these scheduling updates have had limited price impact historically.
Over the past several months, ICU Medical has frequently communicated around investor events and earnings. A prior conferences,earnings date release on Feb 05 detailed the Q4 2025 call timing and was followed by a mild -0.23% move. Subsequent earnings results on Feb 19, 2026 included detailed 2025 metrics and 2026 guidance. Today’s announcement continues that pattern of providing advance visibility into quarterly earnings communications.
Key Terms
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN CLEMENTE, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2026 earnings release and conference call.
The Company will release its first quarter 2026 results on Thursday, May 7, 2026 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, May 7, 2026. The call can be accessed at 1-800-343-4136, conference ID “ICUMED”. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical
ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.
CONTACT:
ICU Medical
Brian Bonnell, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Managing Partner
(646) 277-1254
Source: ICU Medical, Inc.